Share
Linkedin
Twitter
Facebook
Whatsapp
Copy Link
Stanford researchers unveiled Paper2Agent, an open-source AI framework that converts scientific papers into interactive agents. Published in Nature, the tool turns static research into dynamic AI collaborators that can reproduce analyses, apply methods to new data, and even discover new connections between studies—like identifying MPHOSPH9's link to ADHD risk.
Emulate, founded by former Google DeepMind researchers in August, is closing a $700 million funding round at a $3.7 billion valuation. The AI startup focuses on world models that generate interactive 3D environments, marking the third major spinout from DeepMind's London offices this year as venture capitalists compete for top AI research talent.
MIT researchers unveiled xvr, an AI model that adapts to individual patients in five minutes and matches real-time X-rays with preoperative 3D scans in seconds with sub-millimeter precision. Published in Nature, the system outperformed existing AI methods by an order of magnitude and could make life-saving procedures like emergency stroke interventions more accessible.
IonQ presented research at IEEE Quantum Week showing how a trained generative AI model can create quantum optimization circuits directly, eliminating costly parameter tuning loops. The collaboration with Oak Ridge National Laboratory, NVIDIA, and University of Tennessee demonstrated that circuit-finding time dropped from over 11 minutes to approximately 28 seconds while improving solution quality.
Major AI labs including Anthropic and OpenAI report significant progress toward recursive self-improvement, where AI systems autonomously enhance their own capabilities. Anthropic's Claude now leads 26% of model R&D work, while industry leaders including Dario Amodei and Sam Altman call for slowing development pace amid fears of runaway superintelligence and loss of human control.
ByteDance has completed a $290 million fundraising round for Anew Labs, its newly independent AI drug discovery unit, achieving a $1.5 billion valuation. The ByteDance spin-off attracted leading investors including HSG, IDG Capital, and Hillhouse Investment, while ByteDance retains 56% ownership of the Shanghai-based company.
Insilico Medicine announced Longevity Vaccines, a research initiative using AI-driven drug discovery to develop single-dose therapies that eliminate senescent cells. The programmable circular RNA platform targets cellular drivers of age-related diseases, starting with immunosenescence. The company reported $106 million revenue in H1 2026, marking its first profitable half-year.
Seattle-based Nuance Labs raised $50 million in Series A funding to develop a full-duplex foundational AI model that perceives and responds to real-time human expression. Founded by former Apple researchers, the startup aims to fix the awkwardness of AI avatars by processing tone, gaze, and conversational cues simultaneously rather than chaining separate tools together.
OpenAI announced its AI model solved the Millennium Prize Problem related to Navier-Stokes equations, proving they can produce singularities. But the claim sparked fierce debate over credit attribution, with mathematicians questioning whether AI tools absorbed unpublished work and whether the solution addresses the problem they actually care about.
Stanford Medicine researchers developed TranscriptFormer, an AI model trained on 112 million cells from 12 species that maps gene expression patterns across organisms. The model can identify cell types in new species, distinguish healthy from diseased cells, and may eventually guide designing new cell-based treatments for complex diseases.
Lawrence Livermore National Laboratory unveiled an AI-powered inspection system that monitors 3D printers layer by layer using machine learning and computer vision. The system analyzes parts in milliseconds—100,000 times faster than manual inspection—enabling real-time defect detection before components leave the printer.
The UK Atomic Energy Authority and Princeton Plasma Physics Laboratory announced plans to link their AI supercomputers—SUNRISE and STELLAR-AI—creating a federated system for AI models trained on data from spherical tokamak facilities. The partnership aims to build digital twins for fusion reactors and accelerate fusion energy research toward commercial power plants.
Two breakthrough studies demonstrate how AI tools are transforming lung cancer treatment decisions. An AI algorithm achieved 91% accuracy in assessing pathologic response to neoadjuvant chemoimmunotherapy in NSCLC patients, while the I3LUNG project's AI models outperformed standard biomarkers in predicting immunotherapy outcomes across 2,396 patients from six international centers.
Tempus AI announced plans to build a research platform containing 100,000 whole genomes linked to longitudinal clinical information. This will be the first de-identified multimodal whole-genome sequencing dataset built around disease populations and patient outcomes, optimized for AI-driven research. The company plans to expand to one million genomes after completing the initial dataset.
Beijing-based AI developer Z.AI raised $5 billion through a discounted share placement and convertible bond sale, its second major capital raise in two months. The Hong Kong-listed company sold shares at a 10% discount while issuing $3 billion in zero-coupon bonds, causing its stock to plunge over 10% to a 5-1/2-month low as investors reacted to potential dilution.
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.